Healthcare - Page 21
Stories from Healthcare come first, newest first, then stories from connected topics (healthcare AI, AI Science & Health, Hub: Tech for Good, Medicine, AI, AI for science), each labelled with where it comes from. This view is not indexed by search engines.
Latest
OpenAI Buys Orchestra Bio to Put Drug-Programme Agents in Rosalind
OpenAI has bought Orchestra Bio, whose AI agents track studies and timelines in drug development, to fold into its Rosalind life-sciences suite. No price.
Anthropic Says Claude Designed Binders Against Scorpion Neurotoxins
Anthropic says Claude designed protein binders against scorpion neurotoxins, with 17 of 211 tested designs meeting its criteria. It claims no antivenom.
Lilly Taps Metis TechBio’s AI to Steer Medicines to Target Tissues
Metis TechBio will use AI to design tissue-targeted drug carriers for Eli Lilly. Upfront cash is low double-digit millions; milestones run up to $1.1bn.
Scripps Research Gets Over 14 Million GPU Hours From Huang Foundation
Scripps Research gets more than 14 million GPU hours from the Huang Foundation via CoreWeave/NVIDIA. In-kind; no dollar value.
Johns Hopkins-Led Team Wins Up to $52.1m to Model Protein Misfolding
Johns Hopkins leads an ARPA-H award of up to $52.1m over four years for an open protein-misfolding AI model, starting with Parkinson’s and Ewing sarcoma.
Google Research Runs AI Agents on Wet-Lab Robots in Closed Loops
Google Research: VERID digital twin on PyLabRobot, closed-loop aptamers, nanomolar FAP binders. Authors’ self-published results, not peer-reviewed.
CERN and Mistral Sign Intent to Build a Large Physics Model
CERN and Mistral signed a statement of intent to develop a Large Physics Model for collider physics. The model is not built yet; no timeline disclosed.
Sanofi Options First Development Candidate From Its Recursion AI Collaboration
Sanofi has optioned a potential first-in-class oral immunology candidate from Recursion, triggering a $10m milestone. Phase 1 is planned for 2027.
insitro and AstraZeneca Sign AI Collaboration to Hunt Drugs for MASH and Cardiomyopathies
insitro gets $40m upfront and is eligible for up to about $1.46bn in potential milestones in an AstraZeneca AI deal for MASH and heart disease.
NVIDIA Pledges Tools and Compute to the EU’s AI in Science Enablers
NVIDIA joined the European Commission's AI in Science Enablers initiative at the Dublin summit, pledging tools, compute and training for researchers.
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.
